Physician

Carlos Enrique Moravek, MD

According to 2025 Medicare claims, Carlos Moravek, MD (NPI: 1194876979) practices physical medicine and rehabilitation in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is VIRGINIA MASON MEDICAL CENTER (NPI: 1922156785; TIN: 910565539) and primary practice location at 98101-2756. Moravek is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and Jefferson Accountable Care, LLC (ACO ID: A5275), participating under the MSSP model.

Moravek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 452 traditional Medicare patients, billed 34,526 HCPCS/CPT codes, and received $672,734 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 906 prescription claims across 313 beneficiaries totaling $14,013 in drug costs, led by Gabapentin (Gabapentin). Open Payments data shows 1 records totaling $96. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $70,690 to $672,734. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,977 and ending at $14,013. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	294	898	$70,690
2016	159	1,570	$76,346
2017	144	975	$71,831
2018	142	1,227	$68,655
2019	127	672	$55,171
2020	105	777	$51,903
2021	192	866	$78,900
2022	153	1,122	$58,830
2023	403	10,875	$306,368
2024	452	34,526	$672,734

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	59	137	$1,977
2016	83	314	$5,285
2017	64	213	$6,969
2018	59	194	$3,835
2019	58	226	$23,018
2020	53	206	$7,090
2021	43	135	$5,064
2022	39	76	$1,478
2023	257	645	$14,042
2024	313	906	$14,013

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	98	98	$176
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	160	220	$150
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	102	102	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	139	180	$105
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	62	72	$74

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gabapentin	Gabapentin	274	10,385	$5,156
Pregabalin	Pregabalin	57	2,419	$2,635
Methylprednisolone	Methylprednisolone	140	841	$1,069
Naproxen	Naproxen	114	3,420	$940
Duloxetine Hcl	Duloxetine Hcl	49	1,490	$781

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$96	SPR Therapeutics, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carlos Enrique Moravek, MD?

Tedicare shows public-source Medicare data for Carlos Enrique Moravek, MD (NPI 1194876979), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carlos Enrique Moravek, MD have ACO affiliation data?

Carlos Enrique Moravek, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and Jefferson Accountable Care, LLC (MSSP, ACO ID A5275).

What billing organization is linked to Carlos Enrique Moravek, MD?

Carlos Enrique Moravek, MD is linked to VIRGINIA MASON MEDICAL CENTER (billing NPI 1922156785) in the available physician profile data.

Does Carlos Enrique Moravek, MD have Open Payments data?

Carlos Enrique Moravek, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.